Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
AstraZeneca
McKesson
McKinsey
Johnson and Johnson

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EPIDUO

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Epiduo

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00757523 Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris Completed GlaxoSmithKline Phase 4 2008-09-01 The purpose of this study is to compare the effectiveness of two marketed products in subjects with facial acne vulgaris
NCT00757523 Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris Completed Stiefel, a GSK Company Phase 4 2008-09-01 The purpose of this study is to compare the effectiveness of two marketed products in subjects with facial acne vulgaris
NCT00907101 Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes Completed Galderma Laboratories, L.P. Phase 4 2009-06-01 The purpose of this study is to evaluate the effectiveness of Epiduo® Gel in reducing antibiotic sensitive and resistant strains of P acnes in vivo.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Epiduo

Condition Name

Condition Name for Epiduo
Intervention Trials
Acne Vulgaris 18
Acne 8
Local Adverse Effects 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Epiduo
Intervention Trials
Acne Vulgaris 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Epiduo

Trials by Country

Trials by Country for Epiduo
Location Trials
United States 42
India 5
Canada 4
Germany 3
Poland 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Epiduo
Location Trials
Texas 4
Florida 4
Pennsylvania 4
North Carolina 4
California 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Epiduo

Clinical Trial Phase

Clinical Trial Phase for Epiduo
Clinical Trial Phase Trials
Phase 4 12
Phase 3 5
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Epiduo
Clinical Trial Phase Trials
Completed 20
Recruiting 2
Active, not recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Epiduo

Sponsor Name

Sponsor Name for Epiduo
Sponsor Trials
Galderma 5
Galderma Laboratories, L.P. 5
Galderma Laboratorium GmbH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Epiduo
Sponsor Trials
Industry 24
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
McKinsey
McKesson
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.